Northern Trust’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-70,837
Closed -$89K 4875
2022
Q1
$89K Hold
70,837
﹤0.01% 4386
2021
Q4
$82K Buy
70,837
+14,368
+25% +$16.6K ﹤0.01% 4478
2021
Q3
$108K Buy
56,469
+16,587
+42% +$31.7K ﹤0.01% 4381
2021
Q2
$93K Hold
39,882
﹤0.01% 4382
2021
Q1
$108K Buy
39,882
+200
+0.5% +$542 ﹤0.01% 4268
2020
Q4
$96K Buy
39,682
+2,369
+6% +$5.73K ﹤0.01% 4122
2020
Q3
$85K Sell
37,313
-6,326
-14% -$14.4K ﹤0.01% 4000
2020
Q2
$100K Buy
43,639
+15,912
+57% +$36.5K ﹤0.01% 3922
2020
Q1
$48K Hold
27,727
﹤0.01% 3961
2019
Q4
$57K Hold
27,727
﹤0.01% 4036
2019
Q3
$80K Buy
27,727
+11,011
+66% +$31.8K ﹤0.01% 3963
2019
Q2
$66K Buy
16,716
+1
+0% +$4 ﹤0.01% 4037
2019
Q1
$79K Hold
16,715
﹤0.01% 3972
2018
Q4
$38K Hold
16,715
﹤0.01% 4095
2018
Q3
$104K Sell
16,715
-8
-0% -$50 ﹤0.01% 4024
2018
Q2
$114K Sell
16,723
-82,362
-83% -$561K ﹤0.01% 3989
2018
Q1
$833K Buy
99,085
+61,620
+164% +$518K ﹤0.01% 3435
2017
Q4
$348K Sell
37,465
-720
-2% -$6.69K ﹤0.01% 3641
2017
Q3
$446K Sell
38,185
-140
-0.4% -$1.64K ﹤0.01% 3593
2017
Q2
$1.6M Buy
38,325
+33,166
+643% +$1.39M ﹤0.01% 3294
2017
Q1
$251K Buy
5,159
+749
+17% +$36.4K ﹤0.01% 3729
2016
Q4
$145K Buy
4,410
+80
+2% +$2.63K ﹤0.01% 3826
2016
Q3
$177K Buy
4,330
+846
+24% +$34.6K ﹤0.01% 3771
2016
Q2
$114K Sell
3,484
-23,745
-87% -$777K ﹤0.01% 3864
2016
Q1
$1.69M Buy
27,229
+80
+0.3% +$4.95K ﹤0.01% 3071
2015
Q4
$1.15M Buy
27,149
+243
+0.9% +$10.2K ﹤0.01% 3277
2015
Q3
$1.48M Buy
26,906
+17,910
+199% +$982K ﹤0.01% 3184
2015
Q2
$988K Buy
8,996
+3,323
+59% +$365K ﹤0.01% 3349
2015
Q1
$538K Hold
5,673
﹤0.01% 3589
2014
Q4
$318K Sell
5,673
-6
-0.1% -$336 ﹤0.01% 3684
2014
Q3
$411K Buy
5,679
+203
+4% +$14.7K ﹤0.01% 3611
2014
Q2
$822K Buy
5,476
+1,416
+35% +$213K ﹤0.01% 3473
2014
Q1
$591K Buy
+4,060
New +$591K ﹤0.01% 3511